Log in

GOLDIC Therapy Holds Promise as an Orthobiologic Agent: A Systematic Review of the Literature

  • Review Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Introduction

Orthobiologic agents play a significant role in regenerative medicine. The quest for newer and more effective Orthobiologic agents is never-ending, leading to the evolution of more reformed products. GOLDIC (GOLD Induced cytokine) is a recently evolving Orthobiologic agent developed by conditioning autologous serum with gold particles. We aim to collate the available evidence on GOLDIC and provide a systematic literature review.

Materials and methods

Using Cochrane and PRISMA guidelines literature search was done for GOLDIC. After duplicate removal and exclusions, 62 articles were scrutinized, of which 8 articles qualified for full-text review. A risk-of-bias assessment of the included studies was done.

Results

All articles showed standardized preparation methods of GOLDIC and uniformity in the number of doses administered, except one study. Reproducible results were noted like an increase in plasma gelsolin and improved KOOS, WOMAC, and VAS scores.

Conclusion

GOLDIC has the potential to be a significant Orthobiologic modality considering its standardized preparation techniques, method of administration, and uniformly reproducible outcome measures. However, further high-quality evidence is needed to analyze the clinical efficiency and safety profile of GOLDIC.

Systematic review registration

INPLASY202350027 [https://doi.org/10.37766/inplasy2023.5.0027].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

All data is contained within the manuscript.

References

  1. Chellamuthu, G., Muthu, S., Jeyaraman, M., & Khanna, M. (2021). When surgeons wanted to go beyond their scalpels! – The philosophy of orthopaedic rheumatology. IP International Journal of Orthopaedic Rheumatology, 7(1), 1–2. https://doi.org/10.18231/j.ijor.2021.001

    Article  Google Scholar 

  2. Dhillon, M. S., Behera, P., Patel, S., & Shetty, V. (2014). Orthobiologics and platelet rich plasma. Indian Journal of Orthopaedics, 48(1), 1–9. https://doi.org/10.4103/0019-5413.125477

    Article  PubMed  PubMed Central  Google Scholar 

  3. Themes U. F. O. (2019). The Role of Orthobiologics in Orthopaedics. https://musculoskeletalkey.com/the-role-of-orthobiologics-in-orthopaedics/. Accessed 1.1.2021. https://musculoskeletalkey.com/the-role-of-orthobiologics-in-orthopaedics/. Accessed January 1, 2021

  4. Schneider, U. (2014). First results on the outcome of gold-induced, autologous-conditioned serum (GOLDIC) in the treatment of different lameness-associated equine diseases. Journal of Cell Science & Therapy, 05(151), 2. https://doi.org/10.4172/2157-7013.1000151

    Article  Google Scholar 

  5. Feldt, J., Donaubauer, A.-J., Welss, J., Schneider, U., Gaipl, U. S., & Paulsen, F. (2022). Anti-inflammatory effects of an autologous gold-based serum therapy in osteoarthritis patients. Scientific Reports, 12(1), 3560. https://doi.org/10.1038/s41598-022-07187-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cochrane Handbook for Systematic Reviews of Interventions. /cochrane-handbook-systematic-reviews-interventions. Accessed 6.11.2020. /cochrane-handbook-systematic-reviews-interventions. Accessed November 6, 2020

  7. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. https://journals.plos.org/plosmedicine/article?id=https://doi.org/10.1371/journal.pmed.1000097. Accessed 6.11.2020. https://journals.plos.org/plosmedicine/article?id=https://doi.org/10.1371/journal.pmed.1000097. Accessed November 6, 2020

  8. Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Medical Research Methodology, 14, 43. https://doi.org/10.1186/1471-2288-14-43

    Article  PubMed  PubMed Central  Google Scholar 

  9. Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., & Chipponi, J. (2003). Methodological index for non-randomized studies (minors): Development and validation of a new instrument. ANZ Journal of Surgery, 73(9), 712–716. https://doi.org/10.1046/j.1445-2197.2003.02748.x

    Article  PubMed  Google Scholar 

  10. Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., et al. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed.), 366, l4898. https://doi.org/10.1136/bmj.l4898

    Article  PubMed  Google Scholar 

  11. Tulpule, S., Jeyaraman, M., Jayakumar, T., Jeyaraman, N., Bapat, A., & Yadav, S. (2023). Gold-Induced Cytokine (GOLDIC®) therapy in the management of knee osteoarthritis: An observational study. Cureus, 15(9), e46231. https://doi.org/10.7759/cureus.46231

    Article  PubMed  PubMed Central  Google Scholar 

  12. Godek, P., Szczepanowska-Wolowiec, B., & Golicki, D. (2022). GOLDIC therapy in degenerative lumbar spinal stenosis: Randomized, controlled trial. Regenerative Medicine, 17(10), 709–718. https://doi.org/10.2217/rme-2022-0047

    Article  CAS  PubMed  Google Scholar 

  13. Fürst, A., Veith, G., & Eisenreich, J. (2020). A prospective comparison of the GOLDIC® technique and corticosteroid plus hyaluronic acid injections for arthrogenic lameness in horses. Pferdeheilkunde, 36(3), 196–204. https://doi.org/10.21836/pem20200301

    Article  Google Scholar 

  14. Schneider, U., Kumar, A., Murrell, W., Ezekwesili, A., Yurdi, N. A., & Maffulli, N. (2021). Intra-articular gold induced cytokine (GOLDIC®) injection therapy in patients with osteoarthritis of knee joint: A clinical study. International Orthopaedics, 45(2), 497–507. https://doi.org/10.1007/s00264-020-04870-w

    Article  PubMed  Google Scholar 

  15. Melo, S. N. S., Ezekwesili, A., Yurdi, N. A., Murrell, W. D., & Maffulli, N. (2020). Gold-Induced Cytokine (GOLDIC®) injection therapy in patient with plantar fasciosis: A case report. Indian Journal of Orthopaedics, 54(3), 348–351. https://doi.org/10.1007/s43465-020-00089-4

    Article  PubMed  PubMed Central  Google Scholar 

  16. Schneider U, Wallich R, Felmet G et al (2017). Gold-Induced Autologous Cytokine Treatment in Achilles Tendinopathy. In: Muscle and Tendon Injuries Springer Berlin, Heidelberg: ISAKOS. pp. 411–420.

  17. Jayaram, P., Mitchell, P. J. T., Shybut, T. B., Moseley, B. J., & Lee, B. (2023). Leukocyte-rich platelet-rich plasma is predominantly anti-inflammatory compared with leukocyte-poor platelet-rich plasma in patients with mild-moderate knee osteoarthritis: A prospective, descriptive laboratory study. The American Journal of Sports Medicine, 51(8), 2133–2140. https://doi.org/10.1177/03635465231170394

    Article  PubMed  Google Scholar 

  18. Zhang, J., Zhang, J., Zhang, N., Li, T., Zhou, X., Jia, J., et al. (2020). The effects of platelet-rich and platelet-poor plasma on biological characteristics of BM-MSCs In Vitro. Analytical Cellular Pathology (Amsterdam), 2020, 8546231. https://doi.org/10.1155/2020/8546231

    Article  CAS  PubMed  Google Scholar 

  19. Bansal, H., Leon, J., Pont, J. L., Wilson, D. A., Bansal, A., Agarwal, D., et al. (2021). Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Scientific Reports, 11(1), 3971. https://doi.org/10.1038/s41598-021-83025-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dhurat, R., & Sukesh, M. (2014). Principles and methods of preparation of platelet-rich plasma: A review and author’s perspective. Journal of Cutaneous and Aesthetic Surgery, 7(4), 189–197. https://doi.org/10.4103/0974-2077.150734

    Article  PubMed  PubMed Central  Google Scholar 

  21. Cordes, F., Curaj, A., Simsekyilmaz, S., Schneider, U., & Liehn, E. A. (2017). Anti-inflammatory gold-induced autologous cytokines treatment triggers heart failure after myocardial infarction. Discoveries, 5(4), e80. https://doi.org/10.15190/d.2017.10

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thamizhmathi Thangaraju.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human or animal subjects performed by the any of the authors.

Informed Consent

For this type of study informed consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jeyaraman, M., Packkyarathinam, R., Thangaraju, T. et al. GOLDIC Therapy Holds Promise as an Orthobiologic Agent: A Systematic Review of the Literature. JOIO 58, 858–865 (2024). https://doi.org/10.1007/s43465-024-01167-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43465-024-01167-7

Keywords

Navigation